Filed Pursuant to Rule 424(b)(5)
Registration No. 333-242377
Subject to Completion, dated August 4, 2021
PRELIMINARY PROSPECTUS SUPPLEMENT
TO PROSPECTUS DATED AUGUST 7, 2020
Shares
% Series E Cumulative Redeemable Preferred Stock
(Liquidation Preference $25.00 Per Share)
We are offering to the public shares of our % Series E Cumulative Redeemable Preferred Stock, par value $0.01 per share, which we refer to in this prospectus supplement as the Series E Preferred Stock. This is the initial issuance of the Series E Preferred Stock. We will pay quarterly cumulative cash dividends on the Series E Preferred Stock, in arrears, on the 30th day of January, April, July and October of each year (provided that if any dividend payment date is not a business day, then the dividend which would otherwise have been payable on that dividend payment date may be paid on the next succeeding business day) from and including the date of original issuance at % of the $25.00 per share liquidation preference per annum (equivalent to $ per annum per share). Dividends will be payable, when, as and if authorized by our board of directors and declared by us, to holders of record as they appear in our stock records for the Series E Preferred Stock at the close of business on the applicable record date, which shall be the fifteenth day of the calendar month, whether or not a business day, in which the applicable dividend payment date falls. The first dividend on the Series E Preferred Stock sold in this offering will be payable on October 30, 2021 and will be in the amount of $ per share.
The Series E Preferred Stock may not be redeemed before August , 2026 except under circumstances intended to preserve our qualification as a real estate investment trust, or REIT, for federal income tax purposes and except as described below upon the occurrence of a Change of Control (as defined herein). On or after August , 2026 we may, at our option, redeem any or all of the shares of the Series E Preferred Stock at $25.00 per share, plus any accumulated and unpaid dividends to, but not including, the redemption date. In addition, upon the occurrence of a Change of Control, we may, at our option, redeem any or all of the shares of Series E Preferred Stock on, or within 120 days after, the first date on which such Change of Control occurred for a cash redemption price equal to $25.00 per share, plus any accumulated and unpaid dividends to, but not including, the redemption date. The Series E Preferred Stock has no stated maturity, is not subject to any sinking fund or mandatory redemption and will remain outstanding indefinitely unless repurchased or redeemed by us or converted into our common stock in connection with a Change of Control by the holders of shares of Series E Preferred Stock.
Upon the occurrence of a Change of Control, each holder of shares of Series E Preferred Stock will have the right (subject to our election to redeem the Series E Preferred Stock in whole or in part, as described above, prior to the Change of Control Conversion Date (as defined herein)) to convert some or all of the shares of Series E Preferred Stock held by such holder on the Change of Control Conversion Date into a number of shares of our common stock per share of Series E Preferred Stock equal to the lesser of:
•
the quotient obtained by dividing (i) the sum of the $25.00 liquidation preference per share of the Series E Preferred Stock plus the amount of any accumulated and unpaid dividends thereon to, but not including, the Change of Control Conversion Date (unless the Change of Control Conversion Date is after a dividend record date and prior to the corresponding dividend payment date for the Series E Preferred Stock, in which case no additional amount for such accrued and unpaid dividend will be included in this sum) by (ii) the Common Stock Price (as defined herein); and
•
, or the Share Cap, subject to certain adjustments as explained herein;
in each case, on the terms and subject to the conditions described in this prospectus supplement, including provisions for the receipt, under specified circumstances, of alternative consideration as described in this prospectus supplement.
No current market exists for the Series E Preferred Stock. We have applied to list the Series E Preferred Stock on the New York Stock Exchange, or the NYSE, under the symbol “ABR PrE.” If the application is approved, trading of the Series E Preferred Stock on the NYSE is expected to begin within 30 days after the date of initial issuance of the Series E Preferred Stock. Our common stock is traded on the NYSE under the symbol “ABR.”
To assist us in maintaining our qualification as a REIT, among other purposes, stockholders are generally restricted from owning (or being treated as owning under applicable attribution rules) more than 5.0% by value or number of shares, whichever is more restrictive, of our outstanding shares of common stock or more than 5.0% by value of our outstanding shares of capital stock, unless our board of directors waives these limitations. In addition, except under limited circumstances as described in this prospectus supplement, holders of the Series E Preferred Stock generally do not have any voting rights.
We have granted the underwriters the right to purchase up to an additional shares of Series E Preferred Stock from us to cover over-allotments, if any, on the same terms and conditions set forth above within 30 days of the date of this prospectus supplement.
Investing in our Series E Preferred Stock involves a high degree of risk. See “Risk Factors” beginning on page S-8 of this prospectus supplement and the risks set forth under the heading “Item 1A. Risk Factors” beginning on page 14 of our Annual Report on Form 10-K for the year ended December 31, 2020.
Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of these securities or passed upon the adequacy or accuracy of this prospectus supplement and the accompanying prospectus. Any representation to the contrary is a criminal offense.
|
|
|
Per Share
|
|
|
Total
|
|
Public offering price
|
|
|
|
$ |
|
|
|
|
|
$ |
|
|
|
Underwriting discount
|
|
|
|
$ |
|
|
|
|
|
$ |
|
|
|
Proceeds, before expenses, to us
|
|
|
|
$ |
|
|
|
|
|
$ |
|
|
|
(1)
Assumes no exercise of the underwriters’ over-allotment option.
Delivery of the shares of Series E Preferred Stock is expected to be made on or about August , 2021 only in book-entry form through the facilities of The Depository Trust Company.
Sole Book-Running Manager
Raymond James
The date of this prospectus supplement is August , 2021.